Consolidated Statements of Cash Flows - USD ($) $ in Thousands	11 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net increase (decrease) in net assets resulting from operations	$ 15,302	$ 130,517	$ 61,643
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
Net realized (gain) loss on investments	(172)	(3,946)	(26)
Net realized (gain) loss on foreign currency forward contracts	0	(21)	0
Net change in unrealized (appreciation) depreciation on investments	(1,824)	1,748	(1,976)
Net change in unrealized (appreciation) depreciation on interest rate swaps and options, inclusive of hedging effects	0	7,725	0
Net accretion on debt instruments	(1,139)	(11,796)	(5,165)
Net paydown gain on debt instruments	(188)	(5,366)	(1,000)
Interest received in-kind	0	(2,249)	(419)
Purchases and drawdowns of investments	(909,087)	(2,271,155)	(728,029)
Proceeds from sales and paydowns of investments	87,923	529,960	162,683
Amortization of deferred financing costs	1,106	4,348	1,921
Amortization of deferred offering costs	401	1,460	3,192
Change in operating assets and liabilities:
(Increase) decrease in interest receivable	(6,023)	(6,468)	12
(Increase) decrease in other assets	0	(612)	0
(Increase) decrease in prepaid expenses	(138)	(644)	(275)
Increase (decrease) in interest payable	4,782	25,722	3,042
Increase (decrease) in accrued expenses and other liabilities payable to affiliate	1,064	694	1,360
Increase (decrease) in income incentive fees payable	1,412	2,671	1,382
Increase (decrease) in management fees payable	1,397	2,249	932
Increase (decrease) in deferred tax liability	0	204	1,371
Increase (decrease) in deferred income	614	1,006	753
Increase (decrease) in capital gains incentive fees payable	249	(496)	247
Increase (decrease) in due to affiliate	188	0	(188)
Net cash used in operating activities	(804,133)	(1,594,539)	(498,496)
Cash flows from financing activities
Dividends paid	0	(112,638)	(56,891)
Payments for repurchase of common shares	0	(2,282)	0
Proceeds from issuance of common shares	529,300	723,473	267,410
Borrowings on debt	578,400	2,663,800	719,063
Payments on debt	(255,200)	(1,555,500)	(399,263)
Payments for deferred financing costs	(8,998)	(22,529)	(3,825)
Payments for deferred offering costs	(860)	(1,427)	(3,801)
Net cash provided by financing activities	842,642	1,692,897	522,693
Net change in cash	38,509	98,358	24,197
Cash and restricted cash, beginning of period	0	62,706	38,509
Cash and restricted cash, end of period	38,509	161,064	62,706
Supplemental and non-cash information
Distributions reinvested	0	28,596	2,666
Cash paid during the period for interest	2,284	67,853	37,987
Dividends payable	0	14,602	17,913
The following table provides a reconciliation of cash and restricted cash reported within the consolidated statements of assets and liabilities:
Cash	22,659	89,201	32,210
Restricted cash	15,850	71,863	30,496
Total cash and restricted cash	38,509	161,064	62,706
Foreign currency forward contracts
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts	$ 0	$ (90)	$ 44